{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:28:16Z","timestamp":1785767296883,"version":"3.56.0"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:sec><jats:title>Background and Purpose<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">AVE<\/jats:styled-content> 0991 (<jats:styled-content style=\"fixed-case\">AVE<\/jats:styled-content>) is a non\u2010peptide compound, mimic of the angiotensin (<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ng)\u2010(1\u20137) actions in many tissues and pathophysiological states. Here, we have investigated the effect of <jats:styled-content style=\"fixed-case\">AVE<\/jats:styled-content> on pulmonary remodelling in a murine model of ovalbumin (<jats:styled-content style=\"fixed-case\">OVA<\/jats:styled-content>)\u2010induced chronic allergic lung inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Experimental Approach<\/jats:title><jats:p>We used <jats:styled-content style=\"fixed-case\">BALB<\/jats:styled-content>\/c mice (6\u20138 weeks old) and induced chronic allergic lung inflammation by <jats:styled-content style=\"fixed-case\">OVA<\/jats:styled-content> sensitization (20\u2009\u03bcg\u00b7mouse<jats:sup>\u22121<\/jats:sup>, i.p., four times, 14 days apart) and <jats:styled-content style=\"fixed-case\">OVA<\/jats:styled-content> challenge (1%, nebulised during 30\u2009min, three times per\u00b7week, for 4 weeks). Control and <jats:styled-content style=\"fixed-case\">AVE<\/jats:styled-content> groups were given saline i.p and challenged with saline. <jats:styled-content style=\"fixed-case\">AVE<\/jats:styled-content> treatment (1\u2009mg\u00b7kg<jats:sup>\u22121<\/jats:sup>\u00b7per day, s.c.) or saline (100\u2009\u03bcL\u00b7kg<jats:sup>\u22121<\/jats:sup>\u00b7per day, s.c.) was given during the challenge period. Mice were anaesthetized 72\u2009h after the last challenge and blood and lungs collected. In some animals, primary bronchi were isolated to test contractile responses. Cytokines were evaluated in bronchoalveolar lavage (<jats:styled-content style=\"fixed-case\">BAL<\/jats:styled-content>) and lung homogenates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p>Treatment with <jats:styled-content style=\"fixed-case\">AVE<\/jats:styled-content> of OVA sensitised and challenged mice attenuated the altered contractile response to carbachol in bronchial rings and reversed the increased airway wall and pulmonary vasculature thickness and right ventricular hypertrophy. Furthermore, <jats:styled-content style=\"fixed-case\">AVE<\/jats:styled-content> reduced <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20105 and increased <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201010 levels in the <jats:styled-content style=\"fixed-case\">BAL<\/jats:styled-content>, accompanied by decreased <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ng <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content> levels in lungs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Implications<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">AVE<\/jats:styled-content> treatment prevented pulmonary remodelling, inflammation and right ventricular hypertrophy in <jats:styled-content style=\"fixed-case\">OVA<\/jats:styled-content> mice, suggesting that <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ng\u2010(1\u20137) receptor agonists are a new possibility for the treatment of pulmonary remodelling induced by chronic asthma.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bph.12318","type":"journal-article","created":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T14:25:32Z","timestamp":1376490332000},"page":"835-846","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["<scp>AVE<\/scp> 0991, a non\u2010peptide mimic of angiotensin\u2010(1\u20137) effects, attenuates pulmonary remodelling in a model of chronic asthma"],"prefix":"10.1111","volume":"170","author":[{"given":"M G","family":"Rodrigues\u2010Machado","sequence":"first","affiliation":[{"name":"National Institute of Science and Technology in Nanobiopharmaceutics (INCT\u2010NANOBIOFAR) Department of Physiology and Biophysics Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G S","family":"Magalh\u00e3es","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Nanobiopharmaceutics (INCT\u2010NANOBIOFAR) Department of Physiology and Biophysics Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Cardoso","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Nanobiopharmaceutics (INCT\u2010NANOBIOFAR) Department of Physiology and Biophysics Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Kangussu","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Nanobiopharmaceutics (INCT\u2010NANOBIOFAR) Department of Physiology and Biophysics Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Murari","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Nanobiopharmaceutics (INCT\u2010NANOBIOFAR) Department of Physiology and Biophysics Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M V","family":"Caliari","sequence":"additional","affiliation":[{"name":"Department of Pathology Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Oliveira","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Nanobiopharmaceutics (INCT\u2010NANOBIOFAR) Department of Physiology and Biophysics Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D C","family":"Cara","sequence":"additional","affiliation":[{"name":"Department of Morphology Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L M","family":"Noviello","sequence":"additional","affiliation":[{"name":"Department of Morphology Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F D","family":"Marques","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Nanobiopharmaceutics (INCT\u2010NANOBIOFAR) Department of Physiology and Biophysics Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Pereira","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Nanobiopharmaceutics (INCT\u2010NANOBIOFAR) Department of Physiology and Biophysics Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Q","family":"Lautner","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Nanobiopharmaceutics (INCT\u2010NANOBIOFAR) Department of Physiology and Biophysics Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A S","family":"Santos","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Nanobiopharmaceutics (INCT\u2010NANOBIOFAR) Department of Physiology and Biophysics Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Campagnole\u2010Santos","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Nanobiopharmaceutics (INCT\u2010NANOBIOFAR) Department of Physiology and Biophysics Biological Sciences Institute Federal University of Minas Gerais  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,10]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01649_1.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.04.047"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/808726"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/318029"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(94)90103-1"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.152.5.7582286"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb39808.x"},{"key":"e_1_2_8_9_1","first-page":"437","article-title":"The influence of IL\u20103, IL\u20105, and GM\u2010CSF on normal human eosinophil and neutrophil C3b\u2010induced degranulation","volume":"48","author":"Carlson M","year":"1993","journal-title":"Allergy"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00140.2003"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2011.26.4.367"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000314"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-008-9129-z"},{"key":"e_1_2_8_14_1","first-page":"908","article-title":"Effects of angiotensin II receptor antagonist on expression of collagen III, collagen V, and transforming growth factor beta1 in the airway walls of sensitized rats","volume":"117","author":"Du YC","year":"2004","journal-title":"Chin Med J (Engl)"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.06.002"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.01905.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2007.07.022"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2012.682572"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780068"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.02.001"},{"key":"e_1_2_8_21_1","first-page":"223","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease","volume":"8","author":"Kidd P","year":"2003","journal-title":"Altern Med Rev"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00872.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2010.12.003"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2002.01420.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00469.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301077"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000175237.41573.63"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20080647"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00873.x"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.18.6.2924"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2011.11.002"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.167346"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/795452"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2001.91.3.1035"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.2.9902094"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21321"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000141438.64887.42"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2004000600005"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2006.00239.x"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1432869100"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00227.2003"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.14.8.1019"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.R-07-152"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00465.2007"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00029330-200811020-00018"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000037979.53963.8F"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2012.05.006"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2012.02880.x"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012323"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-011-0264-x"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.12318","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.12318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T21:17:38Z","timestamp":1696281458000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.12318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1111\/bph.12318"],"URL":"https:\/\/doi.org\/10.1111\/bph.12318","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"2013-01-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-07-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}